AC Immune (ACIU) Operating Margin (QoQ) (2015 - 2026)
Analysis
AC Immune (ACIU) Operating Margin (QoQ) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | AC Immune | 285.13 Mn | 285.13 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 132,943.00 |
| Mar 31, 2026 | 293,704.00 |
| Dec 31, 2025 | -253,696.00 |
| Sep 30, 2025 | -23,709.00 |
| Jun 30, 2025 | 47,203.00 |
| Mar 31, 2025 | -31,910.00 |
| Dec 31, 2024 | -166,599.00 |
| Sep 30, 2024 | 307,961.00 |
| Dec 31, 2022 | -186.94 Mn |
| Dec 31, 2020 | -38,744.00 |
| Sep 30, 2020 | -22,606.00 |
| Jun 30, 2020 | -138,902.00 |
| Mar 31, 2020 | 212,926.00 |
| Dec 31, 2019 | -224,253.00 |
| Sep 30, 2019 | 103,157.00 |
| Jun 30, 2019 | -105,793.00 |
| Mar 31, 2019 | 16,838.00 |
| Dec 31, 2018 | 43,981.00 |
| Sep 30, 2018 | 4,249.00 |
| Jun 30, 2018 | 20,603.00 |